<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>Irhythm Technologies Inc — News on 6ix</title>
<link>https://6ix.com/company/irhythm-technologies-inc</link>
<description>Latest news and press releases for Irhythm Technologies Inc on 6ix.</description>
<language>en-us</language>
<lastBuildDate>Tue, 28 Apr 2026 20:05:00 GMT</lastBuildDate>
<generator>6ix RSS</generator>
<atom:link href="https://6ix.com/rss/company/irhythm-technologies-inc" rel="self" type="application/rss+xml" />
<image>
<url>https://6ix-events-pro.s3.amazonaws.com/6ixvideo/logos/org-logo6835852178dffbe2df0fd636.webp</url>
<title>Irhythm Technologies Inc</title>
<link>https://6ix.com/company/irhythm-technologies-inc</link>
</image>
<item>
<title>iRhythm Holdings to Present at the Bank of America Securities 2026 Health Care Conference</title>
<link>https://6ix.com/company/irhythm-technologies-inc/news/irhythm-holdings-to-present-at-the-bank-of-america-securities-2026-health-care-conference</link>
<guid isPermaLink="true">https://6ix.com/company/irhythm-technologies-inc/news/irhythm-holdings-to-present-at-the-bank-of-america-securities-2026-health-care-conference</guid>
<pubDate>Tue, 28 Apr 2026 20:05:00 GMT</pubDate>
<description>SAN FRANCISCO, April 28, 2026 (GLOBE NEWSWIRE) -- iRhythm Holdings, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, prevent, and predict disease, today announced the company will be participating in the upcoming Bank of America Securities 2026 Health Care Conference. iRhythm’s management is scheduled to present on Wednesday, May 13, 2026, 9:20 a.m. Pacific Time/12:20 p.m. Eastern Time. Interested parties may access a live and archived</description>
</item>
<item>
<title>iRhythm Holdings to Report First Quarter 2026 Financial Results on April 30, 2026</title>
<link>https://6ix.com/company/irhythm-technologies-inc/news/irhythm-holdings-to-report-first-quarter-2026-financial-results-on-april-30-2026</link>
<guid isPermaLink="true">https://6ix.com/company/irhythm-technologies-inc/news/irhythm-holdings-to-report-first-quarter-2026-financial-results-on-april-30-2026</guid>
<pubDate>Thu, 16 Apr 2026 20:05:00 GMT</pubDate>
<description>SAN FRANCISCO, April 16, 2026 (GLOBE NEWSWIRE) -- iRhythm Holdings, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, prevent, and predict disease, today announced that it will release financial results for the first quarter 2026 after the close of trading on Thursday, April 30, 2026. The company’s management team will host a corresponding conference call beginning at 1:30 p.m. PT / 4:30 p.m. ET. Interested parties may access a live and</description>
</item>
<item>
<title>Data presented at ACC.26 further demonstrate the benefits of iRhythm’s Zio® ambulatory ECG portfolio across multiple patient populations as company launches new digital education platform</title>
<link>https://6ix.com/company/irhythm-technologies-inc/news/data-presented-at-acc26-further-demonstrate-the-benefits-of-irhythms-zior-ambulatory-ecg-portfolio-across-multiple-patient-populations-as-company-launches-new-digital-education-platform</link>
<guid isPermaLink="true">https://6ix.com/company/irhythm-technologies-inc/news/data-presented-at-acc26-further-demonstrate-the-benefits-of-irhythms-zior-ambulatory-ecg-portfolio-across-multiple-patient-populations-as-company-launches-new-digital-education-platform</guid>
<pubDate>Mon, 30 Mar 2026 04:00:00 GMT</pubDate>
<description>Data presented at ACC.26 demonstrate a high prevalence of clinically actionable arrhythmias across CKM patient populations using the Zio® ambulatory ECG</description>
</item>
<item>
<title>iRhythm Holdings Appoints Jason Patten to its Board of Directors</title>
<link>https://6ix.com/company/irhythm-technologies-inc/news/irhythm-holdings-appoints-jason-patten-to-its-board-of-directors</link>
<guid isPermaLink="true">https://6ix.com/company/irhythm-technologies-inc/news/irhythm-holdings-appoints-jason-patten-to-its-board-of-directors</guid>
<pubDate>Thu, 12 Mar 2026 20:30:00 GMT</pubDate>
<description>SAN FRANCISCO, March 12, 2026 (GLOBE NEWSWIRE) -- iRhythm Holdings, Inc. (NASDAQ: IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict, and prevent disease, is pleased to announce the appointment of Jason Patten to its Board of Directors, effective March 12, 2026. Mr. Patten brings decades of strategic leadership in healthcare, reinforcing iRhythm’s commitment to innovation, operational excellence, and long-term growth. “We are thrilled to welco</description>
</item>
<item>
<title>iRhythm Holdings Announces Fourth Quarter and Full Year 2025 Financial Results</title>
<link>https://6ix.com/company/irhythm-technologies-inc/news/irhythm-holdings-announces-fourth-quarter-and-full-year-2025-financial-results</link>
<guid isPermaLink="true">https://6ix.com/company/irhythm-technologies-inc/news/irhythm-holdings-announces-fourth-quarter-and-full-year-2025-financial-results</guid>
<pubDate>Thu, 19 Feb 2026 21:05:00 GMT</pubDate>
<description>SAN FRANCISCO, Feb. 19, 2026 (GLOBE NEWSWIRE) -- iRhythm Holdings, Inc. (NASDAQ: IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict, and prevent disease, today reported financial results for the three months and full year ended December 31, 2025. Fourth Quarter 2025 Financial Highlights Revenue of $208.9 million, a 27.1% increase compared to fourth quarter 2024Gross margin of 70.9%, a 90-basis point increase compared to fourth quarter 2024Net</description>
</item>
<item>
<title>iRhythm Holdings to Report Fourth Quarter and Full Year 2025 Financial Results on February 19, 2026</title>
<link>https://6ix.com/company/irhythm-technologies-inc/news/irhythm-holdings-report-fourth-quarter-213000902</link>
<guid isPermaLink="true">https://6ix.com/company/irhythm-technologies-inc/news/irhythm-holdings-report-fourth-quarter-213000902</guid>
<pubDate>Thu, 05 Feb 2026 21:30:00 GMT</pubDate>
<description>SAN FRANCISCO, Feb. 05, 2026 (GLOBE NEWSWIRE) -- iRhythm Holdings, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, prevent, and predict disease, today announced that it will release financial results for the fourth quarter and full year 2025 after the close of trading on Thursday, February 19, 2026. The company’s management team will host a corresponding conference call beginning at 1:30 p.m. PT / 4:30 p.m. ET. Interested parties may a</description>
</item>
<item>
<title>iRhythm Technologies, Inc. Shares Preliminary Fourth Quarter 2025 Highlights and Business Update at the 44th Annual J.P. Morgan Healthcare Conference</title>
<link>https://6ix.com/company/irhythm-technologies-inc/news/irhythm-technologies-inc-shares-preliminary-123000723</link>
<guid isPermaLink="true">https://6ix.com/company/irhythm-technologies-inc/news/irhythm-technologies-inc-shares-preliminary-123000723</guid>
<pubDate>Mon, 12 Jan 2026 12:30:00 GMT</pubDate>
<description>SAN FRANCISCO, Jan. 12, 2026 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC) a leading digital health care company focused on creating trusted solutions that detect, predict, and prevent disease, today announced preliminary fourth quarter operational highlights and a business update at the 44th Annual J.P. Morgan Healthcare Conference. Recent Operational Highlights and Financial Outlook Anticipate full year 2025 revenue to exceed high end of previously stated guidance range of $740</description>
</item>
<item>
<title>iRhythm Technologies to Present at the 44th Annual J.P. Morgan Healthcare Conference</title>
<link>https://6ix.com/company/irhythm-technologies-inc/news/irhythm-technologies-present-44th-annual-jp-morgan-healthcare-conference-2025-12-29</link>
<guid isPermaLink="true">https://6ix.com/company/irhythm-technologies-inc/news/irhythm-technologies-present-44th-annual-jp-morgan-healthcare-conference-2025-12-29</guid>
<pubDate>Mon, 29 Dec 2025 05:00:00 GMT</pubDate>
<description>SAN FRANCISCO, Dec. 29, 2025 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted</description>
</item>
<item>
<title>New Data at the Asia Pacific Heart Rhythm Society (APHRS) 2025 Highlight the Performance of iRhythm’s Zio Long-Term Continuous Monitoring in an Asian Population</title>
<link>https://6ix.com/company/irhythm-technologies-inc/news/new-data-asia-pacific-heart-rhythm-society-aphrs-2025-highlight-performance-irhythms</link>
<guid isPermaLink="true">https://6ix.com/company/irhythm-technologies-inc/news/new-data-asia-pacific-heart-rhythm-society-aphrs-2025-highlight-performance-irhythms</guid>
<pubDate>Fri, 21 Nov 2025 05:00:00 GMT</pubDate>
<description>iRhythm Technologies presented new data during the joint Asia Pacific Heart Rhythm Society (APHRS) and Japan Heart Rhythm Society (JHRS) scientific</description>
</item>
<item>
<title>iRhythm Technologies Announces Publication of Large-Scale Study in Heart Rhythm and New Data Presented at AHA Scientific Sessions 2025</title>
<link>https://6ix.com/company/irhythm-technologies-inc/news/irhythm-technologies-announces-publication-large-scale-study-heart-rhythm-and-new</link>
<guid isPermaLink="true">https://6ix.com/company/irhythm-technologies-inc/news/irhythm-technologies-announces-publication-large-scale-study-heart-rhythm-and-new</guid>
<pubDate>Tue, 11 Nov 2025 05:00:00 GMT</pubDate>
<description>Real-world data across more than 1 million patients published in Heart Rhythm show that 24–48-hour monitoring can miss actionable arrhythmias and highlights</description>
</item>
<item>
<title>iRhythm Technologies to Participate in Upcoming Investor Conferences</title>
<link>https://6ix.com/company/irhythm-technologies-inc/news/irhythm-technologies-participate-upcoming-investor-conferences-2025-11-04</link>
<guid isPermaLink="true">https://6ix.com/company/irhythm-technologies-inc/news/irhythm-technologies-participate-upcoming-investor-conferences-2025-11-04</guid>
<pubDate>Tue, 04 Nov 2025 05:00:00 GMT</pubDate>
<description>SAN FRANCISCO, Nov. 04, 2025 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted</description>
</item>
<item>
<title>iRhythm Technologies Announces Third Quarter 2025 Financial Results</title>
<link>https://6ix.com/company/irhythm-technologies-inc/news/irhythm-technologies-announces-third-quarter-2025-financial-results-2025-10-30</link>
<guid isPermaLink="true">https://6ix.com/company/irhythm-technologies-inc/news/irhythm-technologies-announces-third-quarter-2025-financial-results-2025-10-30</guid>
<pubDate>Thu, 30 Oct 2025 04:00:00 GMT</pubDate>
<description>SAN FRANCISCO, Oct. 30, 2025 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital health care company focused on creating trusted</description>
</item>
<item>
<title>iRhythm Technologies to Report Third Quarter 2025 Financial Results on October 30, 2025</title>
<link>https://6ix.com/company/irhythm-technologies-inc/news/irhythm-technologies-report-third-quarter-2025-financial-results-october-30-2025-2025</link>
<guid isPermaLink="true">https://6ix.com/company/irhythm-technologies-inc/news/irhythm-technologies-report-third-quarter-2025-financial-results-october-30-2025-2025</guid>
<pubDate>Thu, 16 Oct 2025 04:00:00 GMT</pubDate>
<description>SAN FRANCISCO, Oct. 16, 2025 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted</description>
</item>
<item>
<title>AMALFI Randomized Clinical Trial Results Demonstrate Increased Atrial Fibrillation Diagnosis with Home-Based Long-Term Continuous ECG Monitoring Using iRhythm Technologies’ Zio LTCM Service</title>
<link>https://6ix.com/company/irhythm-technologies-inc/news/amalfi-randomized-clinical-trial-results-demonstrate-increased-atrial-fibrillation-0</link>
<guid isPermaLink="true">https://6ix.com/company/irhythm-technologies-inc/news/amalfi-randomized-clinical-trial-results-demonstrate-increased-atrial-fibrillation-0</guid>
<pubDate>Fri, 29 Aug 2025 04:00:00 GMT</pubDate>
<description>Oxford University-led AMALFI clinical trial results presented at the European Society of Cardiology (ESC) Congress 2025 and published in the Journal of the</description>
</item>
<item>
<title>AVALON Real-World Evidence Builds on CAMELOT Study Reinforcing iRhythm’s Zio LTCM Clinical Superiority</title>
<link>https://6ix.com/company/irhythm-technologies-inc/news/avalon-real-world-evidence-builds-camelot-study-reinforcing-irhythms-zio-ltcm</link>
<guid isPermaLink="true">https://6ix.com/company/irhythm-technologies-inc/news/avalon-real-world-evidence-builds-camelot-study-reinforcing-irhythms-zio-ltcm</guid>
<pubDate>Mon, 18 Aug 2025 04:00:00 GMT</pubDate>
<description>In the largest real-world study of its kind with 428,707 patients, the Zio LTCM service outperformed other studied monitoring approaches in cardiac arrhythmia</description>
</item>
<item>
<title>iRhythm and Lucem Health Partner to Introduce Predictive AI Solution for Early Detection of Arrhythmias in Patient Populations with Comorbid Conditions</title>
<link>https://6ix.com/company/irhythm-technologies-inc/news/irhythm-and-lucem-health-partner-introduce-predictive-ai-solution-early-detection</link>
<guid isPermaLink="true">https://6ix.com/company/irhythm-technologies-inc/news/irhythm-and-lucem-health-partner-introduce-predictive-ai-solution-early-detection</guid>
<pubDate>Thu, 31 Jul 2025 04:00:00 GMT</pubDate>
<description>Partnership aims to utilize predictive AI to help identify arrhythmias earlier in patient populations with an elevated risk for arrhythmias to enable timely</description>
</item>
<item>
<title>iRhythm Technologies Announces Second Quarter 2025 Financial Results</title>
<link>https://6ix.com/company/irhythm-technologies-inc/news/irhythm-technologies-announces-second-quarter-2025-financial-results-2025-07-31</link>
<guid isPermaLink="true">https://6ix.com/company/irhythm-technologies-inc/news/irhythm-technologies-announces-second-quarter-2025-financial-results-2025-07-31</guid>
<pubDate>Thu, 31 Jul 2025 04:00:00 GMT</pubDate>
<description>SAN FRANCISCO, July 31, 2025 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital health care company focused on creating trusted</description>
</item>
<item>
<title>iRhythm Technologies to Report Second Quarter 2025 Financial Results on July 31, 2025</title>
<link>https://6ix.com/company/irhythm-technologies-inc/news/irhythm-technologies-report-second-quarter-2025-financial-results-july-31-2025-2025</link>
<guid isPermaLink="true">https://6ix.com/company/irhythm-technologies-inc/news/irhythm-technologies-report-second-quarter-2025-financial-results-july-31-2025-2025</guid>
<pubDate>Thu, 17 Jul 2025 04:00:00 GMT</pubDate>
<description>SAN FRANCISCO, July 17, 2025 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted</description>
</item>
<item>
<title>Integer Appoints Michael Coyle to Board of Directors</title>
<link>https://6ix.com/company/irhythm-technologies-inc/news/integer-appoints-michael-coyle-to-board-of-directors</link>
<guid isPermaLink="true">https://6ix.com/company/irhythm-technologies-inc/news/integer-appoints-michael-coyle-to-board-of-directors</guid>
<pubDate>Thu, 10 Jul 2025 20:52:00 GMT</pubDate>
<description>~ New Director Brings Extensive Medical Device Industry Leadership and Technology Experience to Integer Board ~ PLANO, Texas, July 10, 2025 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE: ITGR), a leading global medical device contract development and manufacturing organization (CDMO), today announced it has appointed Michael Coyle to its Board of Directors. Coyle brings more than 40 years of leadership in the medical device industry to Integer and joins the Board as a member of the Audi</description>
</item>
<item>
<title>iRhythm Technologies Announces Board Member Retirements and New Director Appointments</title>
<link>https://6ix.com/company/irhythm-technologies-inc/news/irhythm-technologies-announces-board-member-retirements-and-new-director-appointments</link>
<guid isPermaLink="true">https://6ix.com/company/irhythm-technologies-inc/news/irhythm-technologies-announces-board-member-retirements-and-new-director-appointments</guid>
<pubDate>Mon, 07 Jul 2025 04:00:00 GMT</pubDate>
<description>SAN FRANCISCO, July 07, 2025 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC) , a leading digital health care company focused on creating trusted</description>
</item>
</channel>
</rss>